Experts outline AE risks—including ICANS, CRS, HLH—as T-cell engager use expands, highlighting the crucial role of nurses and APPs.
Nausheen Ahmed, MD
Advertisement
Nausheen Ahmed, MD, is an associate professor of hematologic malignancies and cellular therapeutics at the University of Kansas Medical Center.
Articles by Nausheen Ahmed, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
FDA Grants Tentative Approval to Generic Olaparib Tablets
2
GU Oncology Trial Logistics: Nursing Insights from Dana-Farber
3
Study Reports 10-Year Outcomes of Focal Therapy for Prostate Cancer
4
Optimizing Multiple Myeloma Care: Insights From a Nursing Expert
5